By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Medical Answers > Does Kadcyla cross the blood brain barrier?

Does Kadcyla cross the blood brain barrier?

Answers by TheMediTary.Com - Last updated: 13-Jul-2023
  • It was believed that Kadcyla was too large to cross the blood brain barrier (BBB).
  • For medicines to treat brain cancer they need to be able to get through the BBB and into the tumor.
  • Recent studies suggest that when there is a brain tumor the BBB may become more leaky allowing Kadcyla (ado-trastuzumab emtansine) to cross into the brain to help treat the brain tumor.

Breast cancer patients have a risk of 5% to 15% of developing brain metastases and if the breast cancer is HER2 positive breast cancer the risk of brain metastases can be higher, up to 25%.

What is the blood brain barrier?

  • The BBB is a barrier that only lets selective substances cross into the brain.
  • It protects the brain from harm by preventing toxins, pathogens, and certain drugs from passing into the brain.
  • For medicines to treat brain cancer they need to be able to get through the BBB and into the tumor.
  • Some medicines are small enough to pass through into the BBB but others are too large.
  • More recently emerging evidence suggests that when a tumor is present in the brain, it may disrupt the BBB so larger medicines may be able to pass through the BBB and reach the tumor.


Kadcyla and the BBB

In the EMILIA clinical study:

  • They looked at HER2 positive breast cancer patients who had CNS metastases without symptoms, who were treated at baseline with Kadcyla.
  • It was noted that overall survival of Kadcyla treated patients was significantly improved when compared with the capecitabine–lapatinib treated patients.
  • Kadcyla effectiveness was thought to be due to the brain tumor making the BBB leaky which let more Kadcyla into the tumor.
  • More studies and clinical trials are needed to determine how effective Kadcyla is against breast cancer that has metastasized to the brain.

Bottom line:

  • Kadcyla was originally thought to be too big to cross the BBB however the EMILIA clinical trial showed an increased overall survival in HER2 positive breast cancer patients who had CNS metastases without symptoms.
  • This suggests that when a brain tumor is present the BBB becomes leaky and Kadcyla was able to pass through the BBB and into the brain tumor.
  • More studies are needed for Kadcyla to check its effectiveness for the treatment of HER2-positive breast cancer that has metastasized to the brain.
Share this Article

Featured questions

  • Is Kadcyla a chemotherapy drug? How does it work?
  • What is tdm1 chemotherapy?
  • How long can you take Kadcyla?
  • Can these drugs be used in Thalassemia patients?
  • How does Lupron (leuprolide) work for prostate cancer?
  • What is the consideration to use nifidepine over amlodipine?
  • Hypertrophic cardiomyopathy/mechanical heart valve?
  • I have been on 400mg of tramadol a day for 20 years, decided its time to come off them
  • Cetirizine - can cetirizine be taken for long periods of time?
  • In the 1960 and 1970 what was used to treat server asthma?
  • High dosage of escitalopram?
  • Citalopram - Why? Does Celexa generally poop out after 4 years?
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch (Hydrocortisone topical)
Centrum Adult (Multivitamins and minerals)
Crovalimab
Cyltezo Prefilled Syringe (Adalimumab)
Zepbound Pen (Tirzepatide)
Mylanta One (Calcium carbonate, magnesium hydroxide, and simethicone)
Uretron Ds (Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate)
Medihoney Wound And Burn Dressing (Topical emollients)
Lidotrode
Libervant (Diazepam (buccal))
Moderna Covid-19 (Covid-19 (6m-11y) vaccine, moderna (2024-2025))
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)
Beqvez (Fidanacogene elaparvovec)

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by